文献速递白内障与屈光手术

国产散光矫正型人工晶状体植入术后5年以上的安全性和有效性

[Safety and efficacy of toric intraocular lens implantation for more than 5 years].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2023-01-01

前瞻性队列研究在9家医院将患者随机分为试验组(Proming® IQ Toric IOL,26眼)和对照组(AcrySof® IQ Toric IOL,19眼),完成5年延续观察。术后5年两组视力均较基线提高且组间无显著差异,柱镜度数较术前角膜散光显著降低,IOL旋转稳定,试验组无IOL闪辉而对照组有5例(26.32%)。结论认为国产Toric IOL远期疗效确切、并发症少且效果稳定。

要点

  • 术后5年两组裸眼远视力、最佳矫正远视力、裸眼近视力、最佳矫正近视力组间差异均无统计学意义,且均较基线提高(均P<0.05)。
  • 术后5年两组客观验光柱镜度数和主觉验光柱镜度数均较术前角膜散光显著降低(均P<0.001)。
  • 术后5年IOL旋转度数试验组3.0°(1.0°,6.0°)vs对照组4.0°(2.0°,6.0°),P=0.574,组间无显著差异。

核心结论

  • 国产Toric IOL植入术后5年矫正白内障伴有规则角膜散光的远期疗效确切,并发症少且效果稳定。

研究设计与样本

  • 前瞻性队列研究,2014年5月至2016年5月在9家医院通过中央动态随机系统分组并完成1年随访的患者(单眼入组)进行延续观察。
  • 试验组植入Proming® IQ Toric IOL(26眼),对照组植入AcrySof® IQ Toric IOL(19眼),共45眼完成5年延续观察,男性17例、女性28例,年龄(72.07±10.67)岁,术后随访(5.39±0.47)年。

主要发现

  • 术后5年裸眼远视力试验组0.20±0.26 vs 对照组0.16±0.13(t=0.17,P=0.752),组间差异无统计学意义。
  • 术后5年最佳矫正远视力试验组0.00(0.00,0.20)vs 对照组0.05±0.10(U=188.00,P=0.880),组间差异无统计学意义。
  • 术后5年裸眼近视力试验组0.50(0.20,0.60)vs 对照组0.42±0.20(U=158.00,P=0.559),组间差异无统计学意义。
  • 术后5年最佳矫正近视力试验组0.13±0.16 vs 对照组0.17±0.23(t=0.14,P=0.645),组间差异无统计学意义。
  • 术后5年两组各项视力相对基线均有提高(均P<0.05)。

关键数值与推荐

  • 术后5年试验组客观验光柱镜度数(-0.67±0.85)D、对照组(-0.73±1.08)D,相对于术前角膜散光试验组(1.27±0.49)D、对照组(1.34±0.82)D均有显著降低(t=-1.50,P=0.149;t=-1.68,P=0.118)。
  • 术后5年试验组主觉验光柱镜度数-0.50(-1.00,0.00)D、对照组(0.69±0.87)D,相对于术前角膜散光均有显著降低(U=36.50,P<0.001;t=6.91,P<0.001)。
  • 术后5年IOL旋转度数试验组3.0°(1.0°,6.0°)vs 对照组4.0°(2.0°,6.0°)(U=185.50,P=0.574),组间差异无统计学意义。
  • 术后5年眼压、视觉不良症状主观评价、视远脱镜情况和总体满意度评价的组间差异均无统计学意义(均P>0.05)。
  • 术后5年试验组后发性白内障7例、对照组4例;试验组未见IOL闪辉,对照组有5例(5/19,26.32%)。

临床怎么用

  • 原文结论认为国产Toric IOL植入术后5年矫正白内障伴有规则角膜散光的远期疗效确切、并发症少且效果稳定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the clinical safety and efficacy of toric intraocular lens (IOL) implantation for more than 5 years. Methods: This study was a prospective cohort study in which subjects were continuously observed over a two-year period (May 2014 to May 2016) in nine hospitals. The study randomly assigned subjects to two groups using a central dynamic randomization system: the study group, which received Proming® IQ toric IOL implants, and the control group, which received AcrySof® IQ toric IOL implants. The subjects completed a one-year follow-up, during which various measures were taken and evaluated, including visual acuity, IOL rotation, postoperative complications, intraocular pressure, and subjective evaluation (preoperatively and at 1 day, 6 months, 1 year, and 5 years post-surgery). The main statistical analysis methods include the Mann-Whitney U test, independent sample t-test, Wilcoxon signed rank test, paired sample t-test, chi-square test, and Fisher's exact test. Results: A total of 45 eyes (26 in the study group and 19 in the control group) completed the five-year continuous observation period. The mean age of the subjects was (72.07±10.67) years and the mean interval from surgery to the last visit was (5.39±0.47) years. After five years, there were no significant differences in uncorrected distance visual acuity (0.20±0.26 vs. 0.16±0.13, t=0.17,P=0.752), best corrected distance visual acuity[0.00(0.00, 0.20) vs. 0.05±0.10, U=188.00, P=0.880], uncorrected near visual acuity[0.50 (0.20, 0.60) vs. 0.42±0.20, t=0.35, P=0.857], and best corrected near visual acuity (0.13±0.16 vs. 0.17±0.23, U=161.00, P=0.884) between the two groups. However, all measures improved significantly from baseline levels in both groups (all P<0.05). Five years after surgery, no matter objective refraction [(-0.67±0.85) D vs. (-0.73±1.08)D] or subjective refraction[-0.50 (-1.00, 0.00)D vs. (0.69±0.87)D], the degree of cylindrical degree is significantly lower than preoperative corneal astigmatism [(1.27±0.49) D vs. (1.34±0.82) D, all P<0.001]. In addition, there were no significant differences in intraocular pressure, subjective evaluation of visual adverse symptoms, distance vision spectacle independence, or overall satisfaction evaluation between the two groups (all P>0.05). The IOL rotation was 3.0°(1.0°, 6.0°) in the study group and 4.0°(2.0°, 6.0°)in the control group (U=185.50,P=0.574), indicating no significant difference between the groups in terms of rotational stability. Five years after surgery, there were 7 cases of posterior capsular opacification in the study group and 4 cases in the control group. There were no cases of IOL glistening in the study group, but 5 cases (26.32%) were observed in the control group. Conclusions: The long-term effects of Proming® toric IOL implantation in correcting cataracts with regular corneal astigmatism are clear after five years, with few complications and stable results. 目的: 评价国产散光矫正型(Toric)人工晶状体(IOL)植入术后5年以上的临床安全性和有效性。 方法: 前瞻性队列研究。对2014年5月至2016年5月在9家医院通过中央动态随机系统分组并完成1年随访的患者(单眼入组)进行延续观察,试验组和对照组分别植入爱博诺德(北京)医疗科技股份有限公司和美国爱尔康公司的Toric IOL。记录术前、术后1 d、6个月、1年、5年的视力、IOL旋转度数、术后并发症、眼压、主观评价等情况。主要统计学分析方法包括Mann-Whitney U检验、独立样本t检验、Wilcoxon符号秩检验、配对样本t检验、卡方检验或Fisher确切检验。 结果: 45例(试验组26例、对照组19例)患者完成5年延续观察,男性17例,女性28例;年龄(72.07±10.67)岁;术后随访(5.39±0.47)年。术后5年,试验组和对照组的裸眼远视力(0.20±0.26、0.16±0.13,t=0.17,P=0.752)、最佳矫正远视力[0.00(0.00,0.20)、0.05±0.10,U=188.00,P=0.880]、裸眼近视力[0.50(0.20,0.60)、0.42±0.20,U=158.00,P=0.559]、最佳矫正近视力(0.13±0.16、0.17±0.23,t=0.14,P=0.645)之间的差异均无统计学意义,且相对基线均有提高(均P<0.05)。术后5年,试验组和对照组的客观验光柱镜度数[(-0.67±0.85)、(-0.73±1.08)D;t=-1.50,P=0.149;t=-1.68,P=0.118]、主觉验光柱镜度数[-0.50(-1.00,0.00)、(0.69±0.87)D;U =36.50,P<0.001;t=6.91,P<0.001]相对于术前角膜散光[试验组(1.27±0.49)D,对照组(1.34±0.82)D]均有显著降低。术后5年,眼压、视觉不良症状主观评价、视远脱镜情况和总体满意度评价的组间差异均无统计学意义(均P>0.05)。旋转稳定性方面,试验组和对照组术后5年的IOL旋转度数分别为3.0°(1.0°,6.0°)、4.0°(2.0°,6.0°),差异无统计学意义(U=185.50,P=0.574)。术后5年,试验组和对照组分别有7例和4例发生后发性白内障;试验组未见IOL闪辉,对照组则有5例(5/19)。 结论: 国产Toric IOL植入术后5年矫正白内障伴有规则角膜散光的远期疗效确切、并发症少且效果稳定。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Song XD, Hao YS, Bao YZ, et al. [Safety and efficacy of toric intraocular lens implantation for more than 5 years]. Zhonghua Yan Ke Za Zhi. 2023. PMID: 36740441. doi:10.3760/cma.j.cn112142-20220826-00417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。